New synthetic compounds appear to prevent brain ...( Spanish chemists have developed a promi...),Health

Spanish chemists have developed a promising set of synthetic compounds that one day could help slow or perhaps halt the progression of Alzheimer's disease and other neurological disorders. The preliminary finding, based on test tube studies by researchers at the Universidad de Granada and others, appears in the Dec. 29 issue of the American Chemical Society's Journal of Medicinal Chemistry.

The compounds, particularly a synthesized metabolite of the hormone melatonin, all inhibit an enzyme called inducible nitric oxide synthase (iNOS), which is needed to produce nitric oxide (NO). NO, a signaling molecule that can activate the immune system, plays an important role in the brain, according to the researchers. But too much NO can trigger the death of brain cells and some scientists theorize the compound is involved in the development of Alzheimer's and Parkinson's diseases.

Like melatonin, the new synthetic compounds apparently can cross biological barriers, suppress iNOS production, and, in turn, prevent NO-induced brain damage, the researchers say. However, they caution that additional research will be needed to verify these results.

The American Chemical Society the world's largest scientific society is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

'"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
21-Dec-2005


Page: 1
Related medicine news :

1. Injection of synthetic polymer may improve facial wasting syndrome associated with HIV
2. Cancer vaccine under development using synthetic protein
3. Study to examine the effects of synthetic steroids
4. New oxidation methods streamline synthesis of important compounds
5. AMPAKINE compounds a new potential treatment for respiratory depression
6. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
7. U of M researchers discover compounds to shrink tumors
8. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue
9. New compounds fight chronic symptoms of bowel disorders
10. Phenolic compounds may explain Mediterranean diet benefits
11. Vitamin D compounds show promise for prevention of prostate cancer